Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Comb Sci ; 19(5): 279-285, 2017 05 08.
Article in English | MEDLINE | ID: mdl-28394123

ABSTRACT

We have achieved a facile synthesis of a combinatorial library of densely substituted pyrazolo[3,4-b]-4,7-dihydropyridines- the mimics of antigenital wart drug podophyllotoxin-from 5-aminopyrazoles and 4-(methylthio) 4H-chromenes. The C(4) pyrazolyl 4H-chromenes, which also possess structural features of podophyllotoxin, were isolable intermediates in the two-step, one-pot condensation. The condensation took place in a one-pot, multicomponent manner when 3-oxo-3-phenylpropanenitriles, hydrazine (precursors for 5-aminopyrazoles) and 4-(methylthio)-4H-chromenes were heated in refluxing ethanol. The condensation, however, stops at 4H-chromene stage when methyl hydrazine or phenylhydrazine were employed. Our findings offer an opportunity for synthesis of a combinatorial library of podophyllotoxin mimics, thus paving the way for discovery of lead candidates for cancer treatment.


Subject(s)
Antineoplastic Agents/chemical synthesis , Dihydropyridines/chemical synthesis , Pyrazoles/chemical synthesis , Small Molecule Libraries/chemical synthesis , Benzopyrans/chemistry , Combinatorial Chemistry Techniques , Drug Discovery , Humans , Hydrazines/chemistry , Nitriles/chemistry , Podophyllotoxin/chemistry
2.
Biomed Pharmacother ; 85: 389-398, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27889234

ABSTRACT

PURPOSE: Previously we showed that BDMC, an analogue of curcumin suppresses growth of human breast and laryngeal cancer cell line by causing apoptosis. Here, we demonstrate the enhanced anti-cancer activity of a heterocyclic ring (indole) incorporated curcumin analogue ((1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-Dione), ICA in short, in comparison to curcumin. METHOD: ICA was synthesized by a one pot condensation reaction. Anti-cancer potential of ICA was assessed in three human cancer cell lines of different origin (Lung adenocarcinoma (A549), leukemia (K562) and colon cancer (SW480)) by MTT assay. Mode of cell death was determined by acridine orange-ethidium bromide (Ao-Eb) staining. Putative cellular targets of ICA were investigated by molecular docking studies. Cell cycle analysis following curcumin or ICA treatment in SW480 cell line was carried out by flow cytometry. Expression levels of Cyclin D1 and apoptotic markers, such as Caspase 3, 8 and 9 were studied by western blot analysis in SW480 cell line treated with or without ICA and curcumin. RESULTS: The yield of ICA synthesis was found to be 69% with a purity of 98%. ICA demonstrated promising anti-cancer activity compared to curcumin alone, as discerned by MTT assay. ICA was non-toxic to the cell line of normal origin. We further observed that ICA is ∼2 fold more potent than curcumin in inhibiting the growth of SW480 cells. Ao-Eb staining revealed that ICA could induce apoptosis in all the cell lines tested. Molecular docking studies suggest that ICA may possibly exhibit its anticancer effect by inhibiting EGFR in A549, Bcr-Abl in K562 and GSK-3ß kinase in SW480 cell line. Moreover, ICA showed strong binding avidity for Bcl-2 protein in silico, which could result in induction of apoptosis. Cell cycle analysis revealed that both curcumin and ICA induced concomitant cell cycle arrest at G0/G1 and G2/M phase. Western blot shows that ICA could effectively down regulate the expression of cell cycle protein cyclin D1, while promoting the activation of Caspase 3, 8 and 9 when compared to curcumin in human colon cancer cell line SW480. CONCLUSION: The result of this study indicates that ICA could hold promise to be a potential anti-cancer agent. Since ICA has shown encouraging results in terms of its anti-cancer activity compared to curcumin, further research is necessary to fully delineate the underlying molecular mechanism of its anticancer potential.


Subject(s)
Antineoplastic Agents/pharmacology , Curcumin/analogs & derivatives , Curcumin/pharmacology , Diarylheptanoids/pharmacology , Indoles/pharmacology , Adenocarcinoma/drug therapy , Apoptosis/drug effects , Binding Sites , Cell Line, Tumor , Colonic Neoplasms/drug therapy , Computer Simulation , Curcumin/chemistry , Diarylheptanoids/chemistry , Gene Expression Regulation/drug effects , Humans , Indoles/chemistry , Leukemia/drug therapy , Lung Neoplasms/drug therapy , Models, Biological , Models, Molecular , Molecular Structure , Protein Conformation , Structure-Activity Relationship
3.
Biofouling ; 32(9): 1029-47, 2016 10.
Article in English | MEDLINE | ID: mdl-27643959

ABSTRACT

Secretory N-acyl homoserine lactones (AHLs) mediate quorum sensing (QS) in bacteria. AHLs are shown to be inhibitory for an unrelated group of bacteria and might mimic host signalling elements, thereby subverting the regulatory events in host cells. This study investigated the AHL produced by Acinetobacter baumannii and analysed its effect on other bacterial species and mammalian cells. Chemically characterized AHL had an m/z value of 325 with a molecular formula C18H31NO4 and showed its inhibitory potential against Staphylococcus aureus. Molecular docking studies identified D-alanine-D-alanine synthetase A, a cell wall synthesizing enzyme of S. aureus having a strong binding affinity towards AHL. Electron microscopy showed the disruption and sloughing off of the S. aureus cell wall when treated with AHL. In vitro experiments revealed that this bacteriostatic AHL showed time-dependent activity and induced apoptosis in cancer cell lines. This compound could be a potential structural backbone for constructing new AHL analogues against S. aureus. The findings emphasize the need to re-evaluate all previously characterized AHLs for any additional new biological functions other than QS.


Subject(s)
Acinetobacter baumannii/metabolism , Acyl-Butyrolactones/pharmacology , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/pharmacology , Quorum Sensing/drug effects , Staphylococcus aureus/drug effects , A549 Cells , Acinetobacter baumannii/genetics , Acinetobacter baumannii/physiology , Acyl-Butyrolactones/isolation & purification , Acyl-Butyrolactones/metabolism , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/metabolism , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/metabolism , Biofilms/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , HeLa Cells , Humans , Molecular Docking Simulation , Staphylococcus aureus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...